Unlike conventional vaccines, nirsevimab — a new RSV shot for infants — is a monoclonal antibody. Its widespread use in children is unprecedented, and long-term safety data is limited.

Substack vax - Trending on BuzzSumo 2024-09-04

Summary:

Unlike conventional vaccines, nirsevimab — a new RSV shot for infants — is a monoclonal antibody. Its widespread use in children is unprecedented, and long-term safety data is limited. substack.com

Link:

https://christine257.substack.com/p/unlike-conventional-vaccines-nirsevimab/comments

From feeds:

Authors:

Christine

Date tagged:

09/04/2024, 01:47

Date published:

09/04/2024, 01:28